Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Board Meeting Date

Mukka Proteins Board Meeting Date

Mukka Proteins intimated a board meeting on 07 Nov 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closure is also disclosed.

Source

BSE filing, NSE: MUKKA. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Mukka Proteins Ltd: key numbers

Share price
₹24.17
Market cap
₹725.1 Cr
Revenue (annual)
₹1,449 Cr
Net profit (annual)
₹52.06 Cr
P/E (TTM)
10.5×Sector 22.8×
Promoter holding
73.33%+0.00% QoQ
FII holding
1.70%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Mukka Proteins Ltd

All →
17:46 IST BSE
Regulatory Approval

Mukka Proteins Regulatory Approval

Mukka Proteins received a US FDA facility registration certificate, valid October 1, 2026 to December 31, 2027. The company says the registration supports its engagement with US customers and markets.

Execution
October 1, 2026 to December 31, 2027

Other board meeting date announcements

All →